Combination of weight loss drugs better for pre-BMS patients than GLP-1s or dieting alone
A study by Pennington Biomedical Research Center's Metamor Institute researchers that evaluated the use of different types of pre-surgery...
top of page
Headlines
Combination of weight loss drugs better for pre-BMS patients than GLP-1s or dieting alone
A study by Pennington Biomedical Research Center's Metamor Institute researchers that evaluated the use of different types of pre-surgery...
Research
Maternal obesity linked to child's heightened hospital admission risk for infection
Children who are born to mothers who are living with severe obesity (BMI of 35 or higher) are at heightened risk of being admitted to...
Combination of weight loss drugs better for pre-BMS patients than GLP-1s or dieting alone
A study by Pennington Biomedical Research Center's Metamor Institute researchers that evaluated the use of different types of pre-surgery...
COURAGE Trial confirms potential to improve the quality of semaglutide-induced weight loss by preserving lean mass
Interim results from the ongoing Phase 2 COURAGE trial - investigating novel combinations of semaglutide (GLP-1 receptor agonist) and...
Comorbid obesity and OSA treatment preferences found to differ among patients and providers
Sleep medicine professionals favour continuous positive airway pressure therapy as treatment for comorbid obesity and obstructive sleep...
Clinical advisory outlines eight key nutritional priorities to support patients on GLP-1 medications
Four leading organisations in lifestyle medicine, obesity medicine, and nutrition - the American College of Lifestyle Medicine (ACLM),...
Obesity contributes to anxiety and cognitive impairment
With rates of obesity and anxiety both on the rise, especially among younger Americans, new research suggests that the two conditions may...
Study to examine how bariatric surgery affects Alzheimer’s disease risk
The National Institute on Aging has awarded a new two-year US$311,000 research grant to the Wisconsin Surgical Laboratory in Metabolism...
GLP-1ra may reduce risk of fourteen obesity-related cancers for people with diabetes
A large observational study of more than 170,000 patients with diabetes and obesity in the US has found that glucagon-like peptide-1...
Allurion Program increases muscle mass and decreases fat mass
A presentation of a study entitled “The swallowable gastric balloon program with AI powered health coach leads to metabolically healthy...
MyPhenome test can predict recurrent weight regain after bariatric surgery
A new study presented by Mayo Clinic researchers at Digestive Disease Week (DDW) has found that the MyPhenome test can help providers...
GLP-1ra receptor agonists role in the management of obesity in Australia
As Australia faces a turning point in obesity management, researchers from Monash University have contributed new insights into the...
GLP-1 prescriptions increase by 364% whilst BMS declines by 42%
Over two percent of adult patients now take a GLP-1 drug to treat overweight or obesity, according to a FAIR Health white paper entitled,...
Industry
All caught up?
New: Directory
Discover global suppliers of specialist bariatric services, treatments, products, and medical equipment.
Events
3rd Annual International Symposium on Magnetic Gastrointestinal and Colon Surgery
Tweets
bottom of page